-
1Academic Journal
المؤلفون: R. Bartsch, N. Harbeck, D. Wrobel, M. Zaiss, J. Terhaag, D. Guth, A. Distelrath, R. Wuerstlein, M.-O. Zahn, D. Lüftner, M. Schwitter, M. Balic, C. Jackisch, V. Müller, G. Rinnerthaler, M. Schmidt, K. Zaman, T. Schinköthe, M. Gorray, U. Breitenstein
المصدر: Breast, Vol 68, Iss , Pp S20-S21 (2023)
مصطلحات موضوعية: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
Relation: http://www.sciencedirect.com/science/article/pii/S0960977623001339; https://doaj.org/toc/1532-3080; https://doaj.org/article/c524022cbe37407da8000e49a3ec5de6
-
2
المؤلفون: Nicole Erickson, Volker Heinemann, Lian Liu, A Joos, P E Ballmer, T Schinkoethe, LJ Storck, F Mumm, Theres Fey, C Eckhardt
المصدر: Supportive Care in Cancer
مصطلحات موضوعية: Male, medicine.medical_specialty, Patient Generated Subjective Global Assessment (PG-SGA), Nutritional Status, 03 medical and health sciences, 0302 clinical medicine, Neoplasms, medicine, Humans, 030212 general & internal medicine, Patient Reported Outcome Measures, Patient participation, Nutrition, Cancer, E-health, business.industry, Nursing research, Malnutrition, Outcome measures, Distress Score, Clinical routine, medicine.disease, Telemedicine, Distress, Cross-Sectional Studies, Nutrition Assessment, Oncology, 030220 oncology & carcinogenesis, Patient-Reported Outcome Measures (PROMs), Physical therapy, Patient-reported outcome, Original Article, Distress thermometer, Female, Patient Participation, business
-
3Academic Journal
المؤلفون: T., Pfitzner, M., Reiser, S., Barth, P., Borchmann, H., Schulz, T., Schinköthe, F., Oberhäuser, J., Wessels, M., Tur, V., Diehl, A., Engert
المصدر: Annals of Hematology ; volume 81, issue 5, page 258-266 ; ISSN 0939-5555 1432-0584
-
4
المؤلفون: Holger Schulz, Peter Staib, T. Schinkoethe, M. Reiser, Peter Borchmann, Andreas Engert, Thomas Elter, Sven Trelle, Michael Hallek
المصدر: Journal of Clinical Oncology. 23:6558-6558
مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, business.industry, Phases of clinical research, medicine.disease, Lymphoma, Fludarabine, Concomitant, Internal medicine, Relapsed refractory, Immunology, medicine, Alemtuzumab, business, medicine.drug